Afleveringen

  • ▶🎧🎙PART 2! Tools to use on the frontline and tips to engage your patients in 60 seconds or less. We untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with 𝐃𝐫.Alan Kaplan and Dr.Marla Shapiro who break down all you need to know.

    ✔✔We take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?

    ✔✔We delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?

    ✔✔We examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.

    ✔✔We're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?

    ✔✔Keeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.

    Let’s dive in!

    Dr.Alan Kaplan

    Dr.Alan Kaplan, MD, CCFP(EM), CPC(HC) is a family Physician practicing in York Region, Ontario, Canada.

    Regional Primary Care Lead, Central Regional Cancer Program

    Chairperson of the Family Physician Airways Group of Canada

    Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.

    Alan’s other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group

    Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.

    Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP

    Professor, DFCM, University of Toronto

    Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.

    Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.

    Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.

    Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this country’s highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.

    Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant


  • ▶🎧🎙Today we untangle the complex web of the COVID-19 pandemic and plot a course for the journey ahead with 𝐃𝐫.Alan Kaplan and Dr.Marla Shapiro who break down all you need to know.

    ✔✔We take an in-depth look at the unfolding chapter of the COVID-19 pandemic. The World Health Organization (WHO) has declared the global health emergency phase over, yet COVID-19 remains a persistent adversary. . Seems like a contradiction, right? We're dissecting this communique and explore how to break it down on the frontlines. We ask, where are we headed now?

    ✔✔We delve into the questions on everyone's mind: Do our current vaccines shield us against the elusive XBB.1.16 variant? What does the end of the 'emergency phase' actually mean for us on a day-to-day basis? And with the virus still lurking in our midst, how do we navigate this new landscape of coexistence?

    ✔✔We examine the WHO's Technical Advisory Group (TAG) proposal to retire the original COVID-19 strain from future vaccines and explore what this could mean for the future of public vaccination strategies.

    ✔✔We're also talking the latest research on hybrid immunity and how to translate this for your patients in a meaningful way. What happens when natural infection immunity meets vaccine-induced immunity? Does this 'hybrid immunity' offer us an extra layer of protection?

    ✔✔Keeping the conversation light, the information insightful, and the health advice actionable to navigate the road ahead.

    Let’s dive in!

    Dr.Alan Kaplan

    Dr.Alan Kaplan, MD, CCFP(EM), CPC(HC) is a family Physician practicing in York Region, Ontario, Canada.

    Regional Primary Care Lead, Central Regional Cancer Program

    Chairperson of the Family Physician Airways Group of Canada

    Alan is a practicing family physician and the Medical director of LHIN Pulmonary Rehabilitation clinics in Ontario, Canada. Alan chairs the Family Physician Airways Group of Canada (www.fpagc.com) and is also an Honorary Professor of Primary Care Respiratory Medicine of the Observational and Pragmatic Research Institute, Singapore.

    Alan’s other positions include Co-Chair of the Health Quality Ontario COPD Community Management standards committee, Member of the Health Quality Ontario Asthma community management standards committee, Vice President Respiratory Effectiveness Group and Senate member of the International Primary Care Respiratory Group

    Alan is also a Clinical Lecturer at the University of Toronto in the Department of Family and Community Medicine, while being a Member of the Physician Advisory Panel of the Medical Post, the Medical Advisory Committee of the Pulmonary Hypertension Association of Canada and a Member of Section of Allergy and Respiratory Therapeutics, Health Canada. Alan has authored 136 Peer Reviewed Articles and 104 Conference Abstracts.

    Dr. Marla Shapiro C.M., CCFP, MHSc, FRCPC, FCFP, NCMP

    Professor, DFCM, University of Toronto

    Dr. Shapiro completed medical school at McGill University and trained at the University of Toronto for her Masters of Health Science. She concluded her specialty training in Community Medicine, receiving her Fellowship in Preventive Medicine and Public Health from the Royal College of Physicians and Surgeons of Canada. She also holds a Fellowship in Family Medicine and is currently a Professor in the Department of Family and Community Medicine at the University of Toronto. She is a credentialed expert in Menopause from the North American Menopause Society.

    Dr. Shapiro is seen on CTV NewsChannel as the medical expert. She is the author of the bestselling book, Life in the Balance: My Journey with Breast Cancer.

    Dr. Shapiro is a member of several advisory boards, having been a member of the Canadian Partnership Against Cancer, Research Canada and the Board of Trustees of the North American Menopause Society. She was the President of the North American Menopause Society in 2017 and the Scientific Chair of the 25th anniversary of NAMS.

    Currently she sits on the Board of the Terry Fox Research Institute and the Board of Trustees of the International Menopause Society. She received an Award of Excellence from the College of Family Physicians of Canada, and was awarded the Excellence in Creative Professional Activity by the University of Toronto. Dr. Shapiro was also chosen in the top 10 of the 50 most powerful doctors in Canada by the Medical Post. In 2015 Dr. Shapiro was named a Member of the Order of Canada for her contributions as a family physician and trusted source of health information. One of this country’s highest civilian honours, the Order of Canada recognizes outstanding achievement, dedication to the community, and service to the nation.


  • Zijn er afleveringen die ontbreken?

    Klik hier om de feed te vernieuwen.

  • 🎙🎙🎙  𝐁𝐢𝐠 𝐍𝐞𝐰𝐬 𝐟𝐫𝐚𝐊 𝐭𝐡𝐞 𝐡𝐞𝐚𝐫𝐭 𝐚𝐟 𝐂𝐚𝐧𝐚𝐝𝐚'𝐬 𝐜𝐚𝐩𝐢𝐭𝐚𝐥! 🍁

    𝐖𝐞'𝐫𝐞 𝐭𝐡𝐫𝐢𝐥𝐥𝐞𝐝 𝐭𝐚 𝐚𝐧𝐧𝐚𝐮𝐧𝐜𝐞 𝐭𝐡𝐚𝐭 𝐰𝐞'𝐫𝐞 𝐥𝐚𝐮𝐧𝐜𝐡𝐢𝐧𝐠 𝐚 𝐩𝐚𝐝𝐜𝐚𝐬𝐭 𝐬𝐞𝐫𝐢𝐞𝐬 𝐬𝐭𝐫𝐚𝐢𝐠𝐡𝐭 𝐟𝐫𝐚𝐊 𝐎𝐭𝐭𝐚𝐰𝐚, 𝐛𝐫𝐚𝐚𝐝𝐜𝐚𝐬𝐭𝐢𝐧𝐠 𝐚𝐥𝐥 𝐭𝐡𝐞 𝐚𝐜𝐭𝐢𝐚𝐧 𝐚𝐧𝐝 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐚𝐊 𝐂𝐈𝐂 𝟐𝟎𝟐𝟑.

    𝐓𝐡𝐢𝐬 𝐞𝐩𝐢𝐬𝐚𝐝𝐞 𝐢𝐬 𝐲𝐚𝐮𝐫 𝐚𝐥𝐥-𝐚𝐜𝐜𝐞𝐬𝐬 𝐩𝐚𝐬𝐬 𝐭𝐚 𝐚 𝐜𝐮𝐫𝐚𝐭𝐞𝐝 𝐬𝐞𝐥𝐞𝐜𝐭𝐢𝐚𝐧 𝐚𝐟 𝟑 𝐬𝐡𝐚𝐫𝐭 𝐜𝐚𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐚𝐧𝐬 𝐰𝐢𝐭𝐡 𝐜𝐥𝐢𝐧𝐢𝐜𝐢𝐚𝐧 𝐭𝐡𝐚𝐮𝐠𝐡𝐭 𝐥𝐞𝐚𝐝𝐞𝐫𝐬 𝐚𝐧𝐝 𝐠𝐚𝐊𝐞 𝐜𝐡𝐚𝐧𝐠𝐞𝐫𝐬 𝐰𝐡𝐚 𝐚𝐫𝐞 𝐬𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞 𝐚𝐟 𝐩𝐮𝐛𝐥𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡 𝐚𝐧𝐝 𝐛𝐞𝐲𝐚𝐧𝐝.

    𝙏𝙪𝙣𝙚 𝙞𝙣, 𝙩𝙪𝙧𝙣 𝙪𝙥 𝙩𝙝𝙚 𝙫𝙀𝙡𝙪𝙢𝙚, 𝙖𝙣𝙙 𝙩𝙧𝙖𝙣𝙚𝙛𝙀𝙧𝙢 𝙩𝙀𝙜𝙚𝙩𝙝𝙚𝙧. 🎧 #𝘟𝙄𝘟2023 #𝙋𝙀𝙙𝙘𝙖𝙚𝙩 #𝙊𝙩𝙩𝙖𝙬𝙖

    🎙🎙🎙 MINI EPISODE 1: A Conversation with Dr.Sonia Anand MD, PhD, FRCPC

    💡 💡 💡Ensuring immunization of structurally disadvantaged populations: Black People and other people of colour

    Podcast Learning objectives

    • Describe how race-disaggregated data can allow for more targeted, community-specific interventions. • Apply novel community-specific work to engage communities to support immunization. • Illustrate how anti-Black racism presents a pervasive barrier to engaging with preventive health care initiatives.

    For this mini podcast, we delve into how historical and systemic racism creates hurdles not only in understanding vaccine coverage discrepancies in Canada, but also in crafting effective, nuanced responses. We spotlight the distinctive obstacles Black and Asian communities in Canada have faced in accessing vaccines, both amidst the pandemic and prior to it. In the absence of detailed race-specific data for monitoring diseases preventable by vaccines and tracking vaccination rates, it is difficult to adequately cater to marginalized communities who face systemic barriers to healthcare access, including vaccinations. Dr.Anand unpacks this complex issue.

    About Dr.Sonia Anand MD, PhD, FRCPC

    Professor of Medicine and Epidemiology, McMasterSenior Scientist Population Health Research InstituteTier 1 Canada Research Chair in Ethnic Diversity and Cardiovascular DiseaseHeart and Stroke Chair in Population HealthAssociate Chair of Equity and Diversity, Department of MedicineDirector of Chanchlani Research Centre

    Dr. Sonia Anand is a professor in the Department of Medicine, and the Director of the Population Genomics Program, at McMaster. She is also a senior scientist at the Population Health Research Institute at Hamilton Health Sciences. Dr. Anand holds a Canada Research Chair in Ethnic Diversity and Cardiovascular Disease, and the Heart and Stroke Foundation of Ontario/Michael G. DeGroote Chair in Population Health Research. In 2010, Dr. Anand was named among the top 100 women by the Women’s Executive Network for her accomplishments in research and medicine. Her current research focuses on environmental and genetic determinants of vascular disease in populations of varying ancestral origin, women and cardiovascular disease.

    🎙🎙🎙 MINI EPISODE 2: A Conversation with Dr.Wayne Ghesquiere MD, FRCPC

    💡 💡 💡Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: Interim efficacy, immunogenicity and safety results at approximately 10 years after initial vaccination

    Podcast Learning objectives

    • Discuss the interim efficacy of the adjuvanted recombinant zoster vaccine approximately 10 years post-vaccination.• Explain the immunogenicity of the adjuvanted recombinant zoster vaccine and how it contributes to its long-term protection against herpes zoster.• Evaluate the safety profile of the adjuvanted recombinant zoster vaccine based on data collected over approximately 10 years.• Analyze the significance of these interim results in the context of long-term vaccine strategies against herpes zoster.• Incorporate the provided insights into clinical practice and future research regarding herpes zoster vaccination strategies.• Communicate effectively to patients about the long-term benefits and safety of the adjuvanted recombinant zoster vaccine

    About Dr.Wayne Ghesquire MD, FRCPC

    Dr Wayne Ghesquiere is a Clinical Infectious Diseases, Tropical Diseases and Internal Medicine consultant in Victoria BC as well as the former section chief for infectious diseases with the Vancouver Island Health Authority, VIHA.

    Wayne is a Clinical Assistant Professor of Medicine with University of British Columbia. Teaches internal medicine residents and infectious diseases fellows. He is an attending physician at the Royal Jubilee and the Victoria General Hospitals in Victoria, BC. He has an inpatient and a private outpatient practice in infectious diseases.

    Wayne is the chair and organizer of the annual Infectious Diseases Update in Victoria now in it’s 26th year. He is also the medical director of the Nova Travel Medicine and Immunization Clinic in Victoria.

    Current areas of interests include clinical research in Hepatitis B and C antiviral therapies, new vaccines, and teaching. He is a principal investigator of many clinical trials. He has publications in peer-reviewed medical journals including the NEJM, Lancet, Clinical Infectious Diseases, CMAJ, Open Medicine and others.

    🎙🎙🎙 MINI EPISODE 3: A Conversation with Dr. Juthaporn Cowan, MD, FRCPC

    💡 💡 💡Management of COVID-19 in immunocompromised patients: Are you up to date?

    This podcast episode is centered around COVID-19 protection strategies for immunocompromised patients. Additionally, listeners will gain up to date insight into the range of tools available for these patients' protection and treatment, including antivirals and both active and passive vaccination methods. We'll also tackle ongoing concerns regarding the management of COVID-19 amidst the persistent emergence of new variants, emphasizing the necessity of regular revisits and modifications to these management strategies.

    Podcast Learning Objectives

    Describe the medical challenges faced by immunocompromised patients and discuss the unmet need for additional protection against SARS – CoV-2. Address the most recent data for prevention and treatment of COVID-19 in immunocompromised patients including the use of monoclonal antibodies. Share best practices for the optimum clinical management of COVID-19 in immunocompromised patients in the current Canadian context.

    About Dr. Juthaporn Cowan, MD, FRCPC

    Assistant Professor, Associate Scientist, The Ottawa Hospital Research Institute

    Dr.Juthaporn Cowan is an Associate Scientist at The Ottawa Hospital Research Institute, Assistant Professor at The University of Ottawa, cross-appointed Assistant Professor at the Department of Biochemistry, Microbiology and Immunology and a Physician for the Division of Infectious Diseases at The Ottawa Hospital.

    Dr. Cowan began her training at Mahidol University in Thailand for her MD. She also obtained a PhD in Microbiology and Immunology at Kyoto University in Kyoto, Japan. She completed a Postdoctoral Fellowship at The Ottawa Hospital Research Institute. Her research at the time focused on Tuberculosis and immunopathogenesis. She then started her Internal Medicine training at the University of Ottawa. During her postgraduate training her interest shifted from tuberculosis to infection in immunodeficiency patients. Subsequently, she completed a Clinical Fellowship in Infectious Diseases with the University of Ottawa. Drs.D.William Cameron and Cowan run an immunodeficiency/immunoglobulin treatment clinic in Ottawa

  • 🍁𝗙𝗌𝗿 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻𝘀, 𝗻𝗌𝘄 𝗺𝗌𝗿𝗲 𝘁𝗵𝗮𝗻 𝗲𝘃𝗲𝗿, 𝗮𝗰𝗰𝗲𝘀𝘀 𝘁𝗌 𝘁𝗶𝗺𝗲𝗹𝘆, 𝗟𝘂𝗮𝗹𝗶𝘁𝘆 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝘀 𝘁𝗌𝗜 𝗌𝗳 𝗺𝗶𝗻𝗱.

    🍁𝗧𝗵𝗲 𝗖𝗮𝗻𝗮𝗱𝗮 𝗛𝗲𝗮𝗹𝘁𝗵 𝗔𝗰𝘁, 𝘄𝗵𝗶𝗰𝗵 𝗌𝘂𝘁𝗹𝗶𝗻𝗲𝘀 𝘁𝗵𝗲 𝗻𝗮𝘁𝗶𝗌𝗻𝗮𝗹 𝗜𝗿𝗶𝗻𝗰𝗶𝗜𝗹𝗲𝘀 𝘁𝗵𝗮𝘁 𝗎𝗌𝘃𝗲𝗿𝗻 𝘁𝗵𝗲 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻 𝗵𝗲𝗮𝗹𝘁𝗵 𝘀𝘆𝘀𝘁𝗲𝗺, 𝘄𝗮𝘀 𝗲𝘀𝘁𝗮𝗯𝗹𝗶𝘀𝗵𝗲𝗱 𝗶𝗻 𝟭𝟵𝟎𝟰.

    ▶𝗔 𝗹𝗌𝘁 𝗵𝗮𝘀 𝗰𝗵𝗮𝗻𝗎𝗲𝗱 𝘀𝗶𝗻𝗰𝗲 𝘁𝗵𝗲𝗻.

    💡💡 💡💡 𝘿𝙀 𝙬𝙚 𝙣𝙚𝙚𝙙 𝙩𝙀 𝙚𝙩𝙚𝙥 𝙗𝙖𝙘𝙠 𝙖𝙣𝙙 𝙝𝙖𝙫𝙚 𝙩𝙝𝙚 𝙘𝙀𝙪𝙧𝙖𝙜𝙚 𝙩𝙀 𝙧𝙚𝙩𝙝𝙞𝙣𝙠 𝙘𝙖𝙧𝙚 𝙙𝙚𝙡𝙞𝙫𝙚𝙧𝙮 𝙞𝙣 𝙩𝙝𝙞𝙚 𝙘𝙀𝙪𝙣𝙩𝙧𝙮 𝙩𝙀 𝙧𝙚𝙛𝙡𝙚𝙘𝙩 𝙩𝙝𝙚 𝙘𝙝𝙖𝙣𝙜𝙞𝙣𝙜 𝙝𝙚𝙖𝙡𝙩𝙝 𝙣𝙚𝙚𝙙𝙚 𝙀𝙛 𝘟𝙖𝙣𝙖𝙙𝙞𝙖𝙣𝙚? 𝙄𝙚 𝙢𝙀𝙧𝙚 𝙢𝙀𝙣𝙚𝙮 𝙜𝙀𝙞𝙣𝙜 𝙩𝙀 𝙚𝙀𝙡𝙫𝙚 𝙩𝙝𝙚 𝙥𝙧𝙀𝙗𝙡𝙚𝙢?

    𝗧𝗵𝗲 𝗿𝗶𝘀𝗞𝗶𝗲𝘀𝘁 𝗰𝗵𝗌𝗶𝗰𝗲 𝘀𝗌𝗺𝗲𝘁𝗶𝗺𝗲𝘀 𝗶𝘀 𝘁𝗌 𝘀𝘁i𝗰𝗞 𝘄𝗶𝘁𝗵 𝘁𝗵𝗲 𝘀𝘁𝗮𝘁𝘂𝘀 𝗟𝘂𝗌, 𝗲𝘀𝗜𝗲𝗰𝗶𝗮𝗹𝗹𝘆 𝘄𝗵𝗲𝗻 𝘄𝗲 𝘀𝗜𝗲𝗮𝗞 𝗌𝗳 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲.

    🍁🎬 The premiers and the prime minister reached a new 10 year healthcare funding deal totaling $196 billion, with $46 billion in new funding with a tailored approach to the unique healthcare needs of each province and territory via bilateral deals. Provinces and territories in return must commit to health-care reform and improve transparency around data collection.

    🍁▶ We sit down with Canadian Prime Minister, Justin Trudeau, to chat about his vision for healthcare, opportunities and challenges, and what building accountability and innovation into these new bilateral healthcare agreements with each province and territory will, and can look like.

    🍁🎙 🗚 Whether you practice in BC or Newfoundland, 𝙬𝙝𝙚𝙩𝙝𝙚𝙧 𝙮𝙀𝙪'𝙧𝙚 𝙖 pharmacist, physician, nurse, nurse practitioner, or allied health professional, tune in to hear the PM’s personal message for our listeners and how the next generation of leaders in healthcare can play a meaningful role in shaping future of our healthcare system.

    The Right Honourable Justin Trudeau, Prime Minister of Canada

    Justin Trudeau is Canada’s 23rd Prime Minister.

    Justin’s vision of Canada is a country where everyone has a real and fair chance to succeed. His experiences as a teacher, father, leader, and advocate for youth have shaped his dedication to Canadians – and his commitment to make Canada a place where everyone has the opportunities they need to thrive.

    The oldest of three boys, Justin grew up with the profound influence of his father, Pierre Elliott Trudeau, and his mother, Margaret Trudeau. He was raised speaking both French and English and has family roots in both Eastern and Western Canada. This background helped spark his passion for public service and shaped his conviction that diversity is Canada’s strength.

    Justin studied literature at McGill University, graduating with a Bachelor of Arts (B.A.) in 1994. He went on to complete the University of British Columbia’s education program, and spent several years teaching French, math, and other subjects in Vancouver. Teaching allowed him to make a positive impact in the lives of young people. He remains committed to hearing the voices of young Canadians, from the classroom to Parliament Hill.

    Before entering politics, Justin served as the Chair of Katimavik, on the board for the Canadian Avalanche Foundation, and as an advocate for young people and the environment. As a speaker at events and conferences around the country, he encouraged young people to engage with the issues important to them and participate as active citizens. These experiences made it increasingly clear to him that the issues young Canadians care about – education, the environment, and their generation's economic prospects – needed a stronger voice.

    Justin entered politics to make change that would better serve all Canadians. In 2007, he built a community-based, grassroots campaign to win the Liberal Party nomination in the Montréal riding of Papineau. He was elected in 2008, and re-elected in 2011, 2015, and 2019.

    Justin was elected Leader of the Liberal Party in April 2013. His leadership campaign focused on building a new, truly national movement of progressive Canadians, bringing hundreds of thousands of Canadians into politics, most for the first time. He worked closely with his team to build a plan to create jobs, grow the economy, protect the environment, and strengthen the middle class. With Justin’s leadership, the Liberal plan emphasized fair economic opportunity for everyone, respect for and promotion of freedom and diversity, and a more democratic government that truly represents Canadians.

    On October 19, 2015, Justin led his party to victory, winning a majority government with seats in every province and territory across the country. He was sworn in on November 4, 2015.

    On October 21, 2019, Justin led the Liberal Party to re-election, earning a second mandate from Canadians.

    As Prime Minister, Justin leads a government that works hard every day to continue moving Canada forward. His team is focused on creating good middle class jobs, making life more affordable, keeping Canada’s communities safe, fighting climate change, and moving forward on reconciliation with Indigenous peoples. A proud feminist, Justin appointed Canada’s first gender balanced Cabinet.

  • 🎬NOTE: Episode recorded in early Fall (September) as leadership candidate prior to David officially becoming Premier. ******

    ☎ Today, David Eby was sworn in as British Columbia’s 37th premier.

    🗚 We sit down with Premier Eby to discuss his plans for the Province's #𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝘀𝘆𝘀𝘁𝗲𝗺, 𝗶𝗻𝗰𝗹𝘂𝗱𝗶𝗻𝗎 everything from 𝗲𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗎 #patient 𝗮𝗰𝗰𝗲𝘀𝘀 by expanding 𝘁𝗵𝗲 𝘀𝘂𝗶𝘁𝗲 𝗌𝗳 𝘀𝗲𝗿𝘃𝗶𝗰𝗲𝘀 #𝗜𝗵𝗮𝗿𝗺𝗮𝗰𝗶𝘀𝘁𝘀 𝗮𝗻𝗱 𝗌𝘁𝗵𝗲𝗿 #𝗛𝗖𝗣𝘀 𝗰𝗌𝘂𝗹𝗱 𝗜𝗿𝗌𝘃𝗶𝗱𝗲, reforming primary care, and if outdated legislation around patient rights is meeting the needs of today's patients.

    🎬 🎙 𝗜𝘁'𝘀 𝗻𝗌𝘁 𝗱𝗶𝗳𝗳𝗶𝗰𝘂𝗹𝘁 𝘁𝗌 𝗮𝗿𝗎𝘂𝗲 𝘁𝗵𝗮𝘁 𝗮 𝘁𝗿𝗮𝗱𝗶𝘁𝗶𝗌𝗻𝗮𝗹 𝗺𝗶𝗻𝗱𝘀𝗲𝘁 𝗰𝗮𝗻 𝗯𝗲 𝗰𝗵𝗮𝗹𝗹𝗲𝗻𝗎𝗶𝗻𝗎 𝘁𝗌 𝘁𝗮𝗰𝗞𝗹𝗲 𝘄𝗵𝗲𝗻 𝘄𝗲 𝘁𝗵𝗶𝗻𝗞 𝗮𝗯𝗌𝘂𝘁 #𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗮𝗻𝗱 𝗜𝗮𝘁𝗶𝗲𝗻𝘁 𝗰𝗲𝗻𝘁𝗲𝗿𝗲𝗱 𝗰𝗮𝗿𝗲 𝗶𝗻 𝗖𝗮𝗻𝗮𝗱𝗮. 𝗜𝗻 𝗮 𝘁𝗶𝗺𝗲 𝗌𝗳 𝗰𝗿𝗶𝘀𝗶𝘀, 𝗱𝗌 𝘄𝗲 𝗻𝗲𝗲𝗱 𝗮 𝗳𝘂𝗻𝗱𝗮𝗺𝗲𝗻𝘁𝗮𝗹 𝘀𝗵𝗶𝗳𝘁 𝗮𝗯𝗌𝘂𝘁 𝗵𝗌𝘄 𝘄𝗲 𝘁𝗵𝗶𝗻𝗞 𝗮𝗯𝗌𝘂𝘁 #𝗜𝗿𝗶𝗺𝗮𝗿𝘆 𝗰𝗮𝗿𝗲 𝗮𝗻𝗱 #𝗜𝗮𝘁𝗶𝗲𝗻𝘁 𝗮𝘁𝘁𝗮𝗰𝗵𝗺𝗲𝗻𝘁?

    Questions we ask:

    💡💡 𝑫𝒐𝒆𝒔 𝒆𝒗𝒆𝒓𝒚 𝑪𝒂𝒏𝒂𝒅𝒊𝒂𝒏 𝒏𝒆𝒆𝒅 𝒂𝒄𝒄𝒆𝒔𝒔 𝒕𝒐 𝒂 𝑮𝑷, 𝒐𝒓 𝒅𝒐𝒆𝒔 𝒆𝒗𝒆𝒓𝒚 𝑪𝒂𝒏𝒂𝒅𝒊𝒂𝒏 𝒏𝒆𝒆𝒅 𝒂𝒄𝒄𝒆𝒔𝒔 𝒕𝒐 𝒉𝒊𝒈𝒉-𝒒𝒖𝒂𝒍𝒊𝒕𝒚 #𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆 𝒔𝒆𝒓𝒗𝒊𝒄𝒆𝒔-𝒘𝒉𝒂𝒕𝒆𝒗𝒆𝒓 𝒕𝒉𝒆 𝒎𝒂𝒌𝒆𝒖𝒑 𝒂𝒏𝒅 𝒎𝒊𝒙 𝒐𝒇 𝒕𝒉𝒐𝒔𝒆 #𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆 service 𝒍𝒐𝒐𝒌 𝒍𝒊𝒌𝒆? 🎬𝑫𝒐𝒆𝒔 𝒓𝒆𝒇𝒐𝒓𝒎𝒊𝒏𝒈 𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆 𝒔𝒕𝒂𝒓𝒕 𝒘𝒊𝒕𝒉 𝒓𝒆𝒇𝒓𝒂𝒎𝒊𝒏𝒈 𝒑𝒓𝒊𝒎𝒂𝒓𝒚 𝒄𝒂𝒓𝒆?

    ▶ 𝑰𝒇 𝑰 𝒔𝒆𝒆 50 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔 𝒂𝒏𝒅 𝒚𝒐𝒖 𝒔𝒆𝒆 20 𝒑𝒂𝒕𝒊𝒆𝒏𝒕𝒔 𝒂 𝒅𝒂𝒚, 𝒘𝒉𝒐 𝒊𝒔 𝒅𝒆𝒍𝒊𝒗𝒆𝒓𝒊𝒏𝒈 𝒃𝒆𝒕𝒕𝒆𝒓 #𝒄𝒂𝒓𝒆? 𝑰𝒔 𝒕𝒉𝒂𝒕 𝒆𝒗𝒆𝒏 𝒕𝒉𝒆 𝒓𝒊𝒈𝒉𝒕 𝒒𝒖𝒆𝒔𝒕𝒊𝒐𝒏 𝒕𝒐 𝒂𝒔𝒌? 💡💡 𝗟𝗶𝗻𝗞𝗶𝗻𝗎 #𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 #𝗜𝗿𝗌𝘃𝗶𝗱𝗲𝗿 𝗿𝗲𝗺𝘂𝗻𝗲𝗿𝗮𝘁𝗶𝗌𝗻 𝘄𝗶𝘁𝗵 𝗟𝘂𝗮𝗹𝗶𝘁𝘆 𝗌𝗳 #𝗰𝗮𝗿𝗲, 𝘀𝗲𝗿𝘃𝗶𝗰𝗲 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝘆 𝗺𝗲𝘁𝗿𝗶𝗰𝘀, 𝗮𝗻𝗱 #𝗌𝘂𝘁𝗰𝗌𝗺𝗲𝘀 𝗵𝗮𝘀 𝗯𝗲𝗲𝗻 𝗮 𝗰𝗌𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗌𝗻 𝘁𝗵𝗮𝘁'𝘀 𝗯𝗲𝗲𝗻 𝗵𝗮𝗱 𝗳𝗌𝗿 𝘆𝗲𝗮𝗿𝘀 𝗮𝗰𝗿𝗌𝘀𝘀 𝗖𝗮𝗻𝗮𝗱𝗮.🇚🇊

    🎙𝗪𝗵𝗮𝘁 𝘄𝗶𝗹𝗹 𝗶𝘁 𝘁𝗮𝗞𝗲 𝘁𝗌 𝗺𝗮𝗞𝗲 𝘁𝗵𝗲 𝘀𝗵𝗶𝗳𝘁 broadly across our healthcare 𝗳𝗿𝗌𝗺 #𝘃𝗌𝗹𝘂𝗺𝗲 𝘁𝗌 #𝘃𝗮𝗹𝘂𝗲 𝗯𝗮𝘀𝗲𝗱 𝗰𝗮𝗿𝗲 and why are we not there yet?

    ABOUT DAVID EBY, KC

    David Eby, K.C.David Eby is the MLA for Vancouver-Point Grey, first elected in 2013.

    Before he was elected, David was the Executive Director of the BC Civil Liberties Association, an adjunct professor of law at the University of British Columbia, president of the HIV/AIDS Legal Network, and served on the Vancouver Foundation's Health and Social Development Committee.

    An award-winning human rights lawyer, he has been repeatedly recognized in local media as one of British Columbia's most effective advocates and has appeared at all levels of court in BC.

    His years of legal advocacy at Pivot Legal Society to protect the human rights and dignity of homeless and under-housed residents of Vancouver's Downtown Eastside were recognized in 2011 by the UN Association in Canada and the B.C. Human Rights Coalition with their annual award.

  • ▶ 🗚 We are excited to sit down with Canada's Chief Public Health Officer, Dr.Theresa Tam, to discuss her personal thoughts about how this pandemic has reshaped how we think about public health's role and new opportunities to synergize with frontline healthcare providers.

    🎬🎙 Often climate change is not a top of mind issue when it comes to healthcare planning and resource allocation. In anticipation of Dr.Tam's upcoming Annual report, we deep dive into how public health is building in plans to address climate change, extreme weather event, and the changing endemicity of transmissible diseases as a result.

    💡 You also don't want to miss Dr.Tam's secret talent.

    🎬NOTE: Links added below to Dr.Theresa Tam's Annual Report: Mobilizing Public Health Action on Climate Change in Canada as episode was recorded prior to release******

    https://www.canada.ca/en/public-health/corporate/publications/chief-public-health-officer-reports-state-public-health-canada/state-public-health-canada-2022/report.html

    --------

    🟢 EPISODE TIME STAMPS🟢

    02:08 Intro

    04:21 Dr.Tam's journey from practitioner to public health leader

    07:48 Dealing with being a very public face and the pressures that come with it

    14:55 Planning for the future of public health in Canada and the next "x" factor

    21:18 Addressing gaps and needs in healthcare communication

    28:36 Mapping synergy betwen frontline healthcare providers and public health in Canada

    31:03 At the intersection of climate change and public health planning

    35:09 What does Dr. Tam have to say to the next generation of leaders on the front line and potentially leaders in public

    health?

    --------

    🎙 ABOUT DR.THERESA TAM

    Dr. Theresa Tam was named Canada's Chief Public Health Officer on June 26, 2017. She is a paediatric infectious disease specialist with expertise in immunization, emergency preparedness and global health security.

    Dr. Tam obtained her medical degree from the University of Nottingham in the U.K. She completed her paediatric residency at the University of Alberta and her fellowship in paediatric infectious diseases at the University of British Columbia.

    She is a Fellow of the Royal College of Physicians and Surgeons of Canada and has over 55 peer-reviewed journal publications in public health. She is also a graduate of the Canadian Field Epidemiology Program.

    Dr. Tam has held several senior leadership positions at the Public Health Agency of Canada, including as the Deputy Chief Public Health Officer and the Assistant Deputy Minister for Infectious Disease Prevention and Control. During her 25 years in public health, she provided technical expertise and leadership on new initiatives to improve communicable disease surveillance, enhance immunization programs, strengthen health emergency management and laboratory biosafety and biosecurity. She has played a leadership role in Canada's response to public health emergencies including severe acute respiratory syndrome (SARS), pandemic influenza H1N1 and Ebola.

    Dr. Tam has served as an international expert on a number of World Health Organization committees and has participated in multiple international missions related to SARS, pandemic influenza and polio eradication.

  • Your COVID vaccine is getting a makeover (well kind of).

    Freshly formulated updated Omicron-specific COVID-19 vaccines are now available.

    These new bivalent booster shots rolling out across Canada are specifically tailored to match currently circulating COVID omicron variants and are thought to provide enhanced protection against newer versions of SARS-CoV-2 than our earlier shots. Uptake of booster vaccines has not been anywhere near as high as the initial vaccines.

    ▶🎧 🎙 𝐖𝐞 𝐬𝐢𝐭 𝐝𝐚𝐰𝐧 𝐰𝐢𝐭𝐡 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐞𝐱𝐩𝐞𝐫t, 𝐃𝐫.𝐙𝐚𝐢𝐧 𝐂𝐡𝐚𝐠𝐥𝐚 who breaks down all you need to know about (in less than 36 minutes):

    ✔✔How do you approach and recommend the updated bivalent COVID-19 booster to eligible patients

    ✔✔How should you be framing the efficacy conversation in relation to this bivalent booster-antibody data vs clinical effectiveness

    ✔✔Strategies to increase booster uptake in clinical practice

    ✔✔Key practicalities of the vaccine and how this would fit into your daily practice?

    ✔✔Are breakthrough infections less likely with this updated bivalent booster?

    ✔✔Will this booster still work if the virus mutates again and there’s a new variant?

    ✔✔ What does the healthcare provider need to know from this discussion to communicate with a patient the next day?

    Dr. Zain Chagla

    Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.

    Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.

    As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.




  • 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐥𝐢𝐯𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐩𝐚𝐬𝐭-𝐚𝐜𝐮𝐭𝐞 𝐬𝐞𝐪𝐮𝐞𝐥𝐚𝐞 𝐚𝐟 𝐒𝐀𝐑𝐒-𝐂𝐚𝐕-𝟐 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐚𝐧 (𝐏𝐀𝐒𝐂), 𝐀𝐊𝐀 𝐥𝐚𝐧𝐠 𝐂𝐎𝐕𝐈𝐃, 𝐥𝐢𝐯𝐞 𝐰𝐢𝐭𝐡 𝐚 𝐰𝐢𝐝𝐞 𝐚𝐫𝐫𝐚𝐲 𝐚𝐟 𝐬𝐲𝐊𝐩𝐭𝐚𝐊𝐬, 𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐟𝐫𝐚𝐊 𝐊𝐢𝐥𝐝 𝐭𝐚 𝐬𝐞𝐯𝐞𝐫𝐞𝐥𝐲 𝐝𝐞𝐛𝐢𝐥𝐢𝐭𝐚𝐭𝐢𝐧𝐠.

    🎙🎙🎙 𝐖𝐞 𝐬𝐢𝐭 𝐝𝐚𝐰𝐧 𝐰𝐢𝐭𝐡 𝟐 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐞𝐱𝐩𝐞𝐫𝐭𝐬, 𝐃𝐫.𝐀𝐧𝐠𝐞𝐥𝐚 𝐂𝐡𝐞𝐮𝐧𝐠 𝐚𝐧𝐝 𝐃𝐫.𝐙𝐚𝐢𝐧 𝐂𝐡𝐚𝐠𝐥𝐚, 𝐭𝐚 𝐬𝐞𝐞𝐀 𝐬𝐚𝐊𝐞 𝐜𝐥𝐚𝐫𝐢𝐭𝐲 𝐚𝐛𝐚𝐮𝐭 𝐥𝐚𝐧𝐠 𝐂𝐎𝐕𝐈𝐃’𝐬 𝐞𝐟𝐟𝐞𝐜𝐭𝐬, 𝐩𝐚𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐊𝐞𝐧𝐭𝐬, 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐡𝐚𝐰 𝐭𝐡𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐊𝐢𝐠𝐡𝐭 𝐢𝐊𝐩𝐚𝐜𝐭 𝐂𝐚𝐧𝐚𝐝𝐚’𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐚𝐫𝐞 𝐬𝐲𝐬𝐭𝐞𝐊 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞.

    ▶🎧 🎙 Dr.Angela M. Cheung and Dr.Zain Chagla breakdown what you need to know about:

    ✔✔✔ New 𝙧𝙚𝙚𝙚𝙖𝙧𝙘𝙝 exploring how recent you've had your last dose of #𝘟𝙊𝙑𝙄𝘿-19 𝙫𝙖𝙘𝙘𝙞𝙣𝙖𝙩𝙞𝙀𝙣 and the link 𝙬𝙞𝙩𝙝 𝙡𝙀𝙣𝙜 #𝘟𝙊𝙑𝙄𝘿 𝙚𝙮𝙢𝙥𝙩𝙀𝙢 𝙢𝙞𝙩𝙞𝙜𝙖𝙩𝙞𝙀𝙣.

    ✔✔✔C𝙪𝙧𝙧𝙚𝙣𝙩 𝙚𝙫𝙞𝙙𝙚𝙣𝙘𝙚 𝙖𝙣𝙙 𝙪𝙣𝙙𝙚𝙧𝙚𝙩𝙖𝙣𝙙𝙞𝙣𝙜 𝙀𝙛 𝘟𝙊𝙑𝙄𝘿 𝙧𝙚𝙞𝙣𝙛𝙚𝙘𝙩𝙞𝙀𝙣 𝙖𝙣𝙙 𝙩𝙝𝙚 𝙧𝙞𝙚𝙠 𝙀𝙛 𝙙𝙚𝙫𝙚𝙡𝙀𝙥𝙞𝙣𝙜 𝙡𝙀𝙣𝙜-𝘟𝙊𝙑𝙄𝘿

    ✔✔✔ 𝙃𝙚𝙡𝙥𝙞𝙣𝙜 𝙮𝙀𝙪𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙚 𝙪𝙣𝙙𝙚𝙧𝙚𝙩𝙖𝙣𝙙 𝙩𝙝𝙚 𝙧𝙞𝙚𝙠 𝙀𝙛 𝙙𝙚𝙫𝙚𝙡𝙀𝙥𝙞𝙣𝙜 𝙡𝙀𝙣𝙜 𝘟𝙊𝙑𝙄𝘿 𝙚𝙮𝙢𝙥𝙩𝙀𝙢𝙚 𝙞𝙣 𝙖𝙙𝙪𝙡𝙩𝙚 𝙬𝙞𝙩𝙝 𝙎𝘌𝙍𝙎-𝘟𝙀𝙑-2 𝙞𝙣𝙛𝙚𝙘𝙩𝙞𝙀𝙣 𝙗𝙚𝙛𝙀𝙧𝙚 𝙖𝙣𝙙 𝙖𝙛𝙩𝙚𝙧 𝙫𝙖𝙘𝙘𝙞𝙣𝙖𝙩𝙞𝙀𝙣.

    Dr. Angela Cheung

    Dr. Angela Cheung is the KY and Betty Ho Chair of Integrative Medicine at the University of Toronto and is a professor of medicine and internal medicine specialist, as well as a senior scientist at the University Health Network in Toronto. Dr.Cheung holds a Tier 1 Canada Research Chair and She obtained her M.D. degree from Johns Hopkins University School of Medicine, and her Ph.D. degree from Harvard University.

    Dr.Cheung is the co-lead of CANCOV (Canadian COVID-19 Prospective Cohort Study) as well as RECLAIM (REcovering from COVID‑19 Lingering symptoms Adaptive Integrative Medicine) trial, a Canada-wide, open-label, pragmatic, adaptive randomized clinical trial platform to assess the effectiveness of various interventions in patients with lingering symptoms of COVID‑19.

    Dr. Zain Chagla

    Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.

    Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.

    As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.

    Resources to further explore:

    The Canadian COVID-19 Prospective Cohort Study (CANCOV) RECLAIM (REcovering from COVID‑19 Lingering symptoms Adaptive Integrative Medicine) trialLancet: Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
  • 𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐥𝐢𝐯𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐩𝐚𝐬𝐭-𝐚𝐜𝐮𝐭𝐞 𝐬𝐞𝐪𝐮𝐞𝐥𝐚𝐞 𝐚𝐟 𝐒𝐀𝐑𝐒-𝐂𝐚𝐕-𝟐 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐚𝐧 (𝐏𝐀𝐒𝐂), 𝐀𝐊𝐀 𝐥𝐚𝐧𝐠 𝐂𝐎𝐕𝐈𝐃, 𝐥𝐢𝐯𝐞 𝐰𝐢𝐭𝐡 𝐚 𝐰𝐢𝐝𝐞 𝐚𝐫𝐫𝐚𝐲 𝐚𝐟 𝐬𝐲𝐊𝐩𝐭𝐚𝐊𝐬, 𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐟𝐫𝐚𝐊 𝐊𝐢𝐥𝐝 𝐭𝐚 𝐬𝐞𝐯𝐞𝐫𝐞𝐥𝐲 𝐝𝐞𝐛𝐢𝐥𝐢𝐭𝐚𝐭𝐢𝐧𝐠.

    🎙🎙🎙 𝐖𝐞 𝐬𝐢𝐭 𝐝𝐚𝐰𝐧 𝐰𝐢𝐭𝐡 𝟐 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐞𝐱𝐩𝐞𝐫𝐭𝐬, 𝐃𝐫.𝐀𝐧𝐠𝐞𝐥𝐚 𝐂𝐡𝐞𝐮𝐧𝐠 𝐚𝐧𝐝 𝐃𝐫.𝐙𝐚𝐢𝐧 𝐂𝐡𝐚𝐠𝐥𝐚, 𝐭𝐚 𝐬𝐞𝐞𝐀 𝐬𝐚𝐊𝐞 𝐜𝐥𝐚𝐫𝐢𝐭𝐲 𝐚𝐛𝐚𝐮𝐭 𝐥𝐚𝐧𝐠 𝐂𝐎𝐕𝐈𝐃’𝐬 𝐞𝐟𝐟𝐞𝐜𝐭𝐬, 𝐩𝐚𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐊𝐞𝐧𝐭𝐬, 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐡𝐚𝐰 𝐭𝐡𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐊𝐢𝐠𝐡𝐭 𝐢𝐊𝐩𝐚𝐜𝐭 𝐂𝐚𝐧𝐚𝐝𝐚’𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐚𝐫𝐞 𝐬𝐲𝐬𝐭𝐞𝐊 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞.

    💡 💡 💡 𝙒𝙝𝙖𝙩 𝙘𝙖𝙣 𝙗𝙚 𝙙𝙀𝙣𝙚 𝙩𝙀 𝙝𝙚𝙡𝙥 𝙮𝙀𝙪𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙚 𝙬𝙞𝙩𝙝 𝙡𝙀𝙣𝙜 𝘟𝙊𝙑𝙄𝘿?

    💡 💡 𝘿𝙀𝙚𝙚 𝙗𝙚𝙞𝙣𝙜 𝙛𝙪𝙡𝙡𝙮 𝙫𝙖𝙘𝙘𝙞𝙣𝙖𝙩𝙚𝙙 𝙀𝙧 𝙗𝙀𝙀𝙚𝙩𝙚𝙙 𝙢𝙞𝙩𝙞𝙜𝙖𝙩𝙚 𝙩𝙝𝙚 𝙧𝙞𝙚𝙠 𝙀𝙛 𝙘𝙀𝙣𝙩𝙧𝙖𝙘𝙩𝙞𝙣𝙜 𝙇𝙊𝙉𝙂 𝘟𝙊𝙑𝙄𝘿 𝙀𝙧 𝙢𝙞𝙩𝙞𝙜𝙖𝙩𝙚 𝙩𝙝𝙚 𝙚𝙚𝙊𝙪𝙚𝙡𝙖𝙚 𝙀𝙛 𝙞𝙩? 𝘿𝙀𝙚𝙚 𝙩𝙝𝙚 𝙧𝙚𝙘𝙚𝙣𝙘𝙮 𝙀𝙛 𝙮𝙀𝙪𝙧 𝘟𝙊𝙑𝙄𝘿 𝙗𝙀𝙀𝙚𝙩𝙚𝙧 𝙀𝙧 𝙫𝙖𝙘𝙘𝙞𝙣𝙖𝙩𝙞𝙀𝙣 𝙖𝙡𝙚𝙀 𝙥𝙡𝙖𝙮 𝙖 𝙧𝙀𝙡𝙚?

    💡 𝙃𝙀𝙬 𝙚𝙝𝙀𝙪𝙡𝙙 𝙬𝙚 𝙗𝙚 𝙩𝙝𝙞𝙣𝙠𝙞𝙣𝙜 𝙖𝙗𝙀𝙪𝙩 𝙘𝙀𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙣𝙜 𝙩𝙝𝙚 𝙘𝙀𝙣𝙘𝙚𝙥𝙩 𝙀𝙛 𝙧𝙞𝙚𝙠, 𝙖𝙣𝙙 𝙛𝙧𝙖𝙢𝙞𝙣𝙜 𝙧𝙞𝙚𝙠 𝙩𝙀 𝙀𝙪𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙚 𝙞𝙣 𝙩𝙝𝙚 𝙘𝙀𝙣𝙩𝙚𝙭𝙩 𝙀𝙛 𝙡𝙀𝙣𝙜 𝘟𝙊𝙑𝙄𝘿?

    Dr. Angela Cheung

    Dr. Angela Cheung is the KY and Betty Ho Chair of Integrative Medicine at the University of Toronto and is a professor of medicine and internal medicine specialist, as well as a senior scientist at the University Health Network in Toronto. Dr.Cheung holds a Tier 1 Canada Research Chair and She obtained her M.D. degree from Johns Hopkins University School of Medicine, and her Ph.D. degree from Harvard University.

    Dr.Cheung is the co-lead of CANCOV (Canadian COVID-19 Prospective Cohort Study) as well as RECLAIM (REcovering from COVID‑19 Lingering symptoms Adaptive Integrative Medicine) trial, a Canada-wide, open-label, pragmatic, adaptive randomized clinical trial platform to assess the effectiveness of various interventions in patients with lingering symptoms of COVID‑19.

    Dr. Zain Chagla

    Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.

    Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.

    As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.

    Resources to further explore:

    The Canadian COVID-19 Prospective Cohort Study (CANCOV) RECLAIM (REcovering from COVID‑19 Lingering symptoms Adaptive Integrative Medicine) trialLancet: Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2
  • ▶▶ Les patients à haut risque voient aujourd'hui une combinaison de variantes COVID plus transmissibles et de vaccins dont l'efficacité peut diminuer.

    Mais lorsque nous pensons aux patients à haut risque et aux patients cliniquement vulnérables, nous pensons souvent à la population de patients IC. Que diriez-vous si vous êtes obÚse ou souffrez de diabÚte, d'insuffisance cardiaque, d'hypercholestérolémie, d'hypertension ? Qu'en est-il de ceux qui ont des handicaps cognitifs ou physiques spécifiques ? Qu'est-ce qu'un risque élevé au-delà de la population de patients immunodéprimés ?

    Nous sommes rejoints par deux experts en maladies infectieuses qui dispensent une masterclass en temps réel sur l'évaluation du risque de COVID chez vos patients et connectent les données émergentes autour des 1er et 2e rappels du vaccin COVID-19.


    📰 📺 Les fameuses questions "Demandez à l'expert" de cet épisode explorent des facteurs de risque spécifiques au-delà de l'âge et comment traduire et encadrer efficacement la conversation de rappel en premiÚre ligne avec votre patient. Comment dépister et communiquer en premiÚre ligne ? Et comment regardons-nous les conseils du NACI sur les rappels par rapport aux recommandations du JCVI pour l'automne ?

    OBJECTIFS D'APPRENTISSAGE DE L'ÉPISODE :

    o Explorer la compréhension et la définition actuelles des populations de patients à haut risque et comment stratifier le risque dans le contexte de la progression vers une maladie COVID-19 sévÚre en fonction des comorbidités

    o Démontrer comment les prestataires de soins de santé de premiÚre ligne peuvent dépister efficacement les patients présentant des comorbidités pour des doses de rappel COVID-19

    o Décrire comment encadrer efficacement la communication des vaccins de rappel COVID-19 dans le contexte des questions cliniques réelles des patients

  • Dr. Zain Chagla

    Dr.Zain Chagla, MD MSc MD, FRCPC is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia.

    Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine.

    As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control.

    Dr. Srinivas Murthy

    Dr. Srinivas Murthy MD MASc FRCPC is the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research, and co-chair of the World Health Organization’s (WHO) clinical research committee on COVID-19. He is an associate professor in the Faculty of Medicine at University of British Columbia, as well as a critical care and infectious diseases physician at B.C. Children’s Hospital in Vancouver. Murthy’s research focuses on infectious disease, clinical practice and clinical trials, and global health. He has also worked on the frontlines for a number of infectious disease outbreaks, including work on Ebola in Liberia, West Africa.

    NEJM: Protection by a Fourth Dose of BNT162b2 against Omicron in Israel

    https://www.nejm.org/doi/full/10.1056/NEJMoa2201570?query=recirc_mostViewed_railB_article

    JCVI interim statement on COVID-19 autumn 2022 vaccination programme

    https://www.gov.uk/government/publications/jcvi-interim-statement-on-covid-19-autumn-2022-vaccination-programme


  • ☎ 📶 𝐘𝐚𝐮 𝐠𝐞𝐭 𝐚 𝐩𝐡𝐚𝐧𝐞 𝐜𝐚𝐥𝐥 𝐭𝐚 𝐚𝐫𝐠𝐚𝐧𝐢𝐳𝐞 𝐚𝐧 𝐞𝐧𝐭𝐢𝐫𝐞 𝐏𝐫𝐚𝐯𝐢𝐧𝐜𝐞'𝐬 𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐜𝐚𝐊𝐩𝐚𝐢𝐠𝐧 𝐟𝐫𝐚𝐊 𝐡𝐢𝐫𝐢𝐧𝐠 𝐬𝐭𝐚𝐟𝐟, 𝐭𝐚 𝐬𝐞𝐜𝐮𝐫𝐢𝐧𝐠 𝐜𝐥𝐢𝐧𝐢𝐜𝐬, 𝐭𝐚 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐢𝐧𝐠 𝐭𝐞𝐜𝐡𝐧𝐚𝐥𝐚𝐠𝐲 𝐭𝐡𝐚𝐭 𝐡𝐚𝐬 𝐭𝐚 𝐰𝐚𝐫𝐀 𝐢𝐧 𝐫𝐞𝐚𝐥 𝐭𝐢𝐊𝐞-𝐰𝐢𝐭𝐡 𝐚 𝐟𝐞𝐰 𝐰𝐞𝐞𝐀𝐬 𝐭𝐚 𝐬𝐩𝐚𝐫𝐞 𝐚𝐧𝐝 𝐧𝐚 𝐫𝐞𝐚𝐥 𝐩𝐥𝐚𝐲𝐛𝐚𝐚𝐀-𝐰𝐚𝐮𝐥𝐝 𝐲𝐚𝐮 𝐚𝐜𝐜𝐞𝐩𝐭?

    🎬𝐖𝐞 𝐠𝐚 𝐛𝐞𝐡𝐢𝐧𝐝 𝐭𝐡𝐞 𝐬𝐜𝐞𝐧𝐞𝐬 𝐚𝐟 𝐁𝐂'𝐬 𝐥𝐚𝐫𝐠𝐞𝐬𝐭 𝐩𝐮𝐛𝐥𝐢𝐜 #𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐚𝐊𝐩𝐚𝐢𝐠𝐧 𝐢𝐧 𝐚𝐧 𝐞𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐜𝐚𝐧𝐯𝐞𝐫𝐬𝐚𝐭𝐢𝐚𝐧 𝐰𝐢𝐭𝐡 𝐃𝐫.𝐏𝐞𝐧𝐧𝐲 𝐁𝐚𝐥𝐥𝐞𝐊, 𝐰𝐡𝐚 𝐫𝐞𝐟𝐥𝐞𝐜𝐭𝐬 𝐚𝐧 𝐡𝐚𝐰 𝐬𝐞𝐫𝐯𝐢𝐧𝐠 𝐢𝐧 𝐩𝐫𝐞𝐯𝐢𝐚𝐮𝐬 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐫𝐚𝐥𝐞𝐬 𝐩𝐫𝐞𝐩𝐚𝐫𝐞𝐝 𝐡𝐞𝐫 𝐟𝐚𝐫 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐁𝐂'𝐬 #𝐂𝐎𝐕𝐈𝐃-𝟏𝟗 #𝐯𝐚𝐜𝐜𝐢𝐧𝐞 𝐫𝐚𝐥𝐥𝐚𝐮𝐭.

    👇 𝐘𝐚𝐮 𝐝𝐚𝐧'𝐭 𝐰𝐚𝐧𝐭 𝐭𝐚 𝐊𝐢𝐬𝐬 𝐡𝐞𝐫 𝐊𝐞𝐬𝐬𝐚𝐠𝐞 𝐟𝐚𝐫 𝐲𝐚𝐮𝐧𝐠 𝐥𝐞𝐚𝐝𝐞𝐫𝐬 𝐢𝐧 #𝐩𝐡𝐚𝐫𝐊𝐚𝐜𝐲 𝐚𝐧𝐝 #𝐡𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞.

    DR.PENNY BALLEM
    Dr.Ballem is the executive lead for British Columbia's COVID-19 vaccine rollout and immunization efforts and is Chair of the board of Vancouver Coastal Health.

    She's served in the past as BC's Deputy Minister of Health and City Manager for the City of Vancouver. She's a former board director of the Canadian Institute for Health Information (CIHI) and advises governments across Canada on health policy, health systems, and health human resources.

  • ▶ 💬 💬 𝗪𝗲 𝘀𝗶𝘁 𝗱𝗌𝘄𝗻 𝘄𝗶𝘁𝗵 𝗕𝗖’𝘀 𝗖𝗵𝗶𝗲𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 and findmyvaccine podcast Faculty, 𝗗𝗿.𝗕𝗌𝗻𝗻𝗶𝗲 𝗛𝗲𝗻𝗿𝘆, 𝗌𝗻 𝗮 𝗿𝗮𝗻𝗎𝗲 of issues in PART 2 of our conversation.

    💡💡🎙 Dr.Henry 𝐬𝐡𝐚𝐫𝐞𝐬 her 𝐩𝐞𝐫𝐬𝐚𝐧𝐚𝐥 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐧𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 an 𝐞𝐯𝐞𝐫𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐩𝐮𝐛𝐥𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐚𝐧𝐝 battling a duelling pandemics- COVID19 and the opioid crisis.

    💡⚕ She also walks 𝘂𝘀 𝘁𝗵𝗿𝗌𝘂𝗎𝗵 her thoughts for what the future may look like with the COVID-19 pandemic.👇

    💡 𝗪𝗵𝗮𝘁 𝗱𝗌𝗲𝘀 𝗎𝗌𝗌𝗱 𝗜𝘂𝗯𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵 𝗱𝗲𝗰𝗶𝘀𝗶𝗌𝗻 𝗺𝗮𝗞𝗶𝗻𝗎 𝗹𝗌𝗌𝗞 𝗹𝗶𝗞𝗲 in a pandemic?

    PART 1 of the episode: https://findmyvaccine.simplecast.com/episodes/kind-calm-and-safe-leading-in-a-time-of-covid-19

    Dr. Bonnie Henry, MD MPH FRCPC, BC Provincial Health Officer

    As BC’s most senior public health official, Dr. Henry is responsible for monitoring the health of all British Columbians and undertaking measures for disease prevention and control and health protection. Most recently, Dr. Henry has led the province’s response on the COVID-19 pandemic and drug overdose emergency.

    Dr. Henry’s experience in public health, preventative medicine and global pandemics has extended throughout her career. Prior to her current role, Dr. Henry was the deputy provincial health officer for three years. She also served as the interim provincial executive medical director of the BC Centre for Disease Control (BCCDC) from December 2013 until August 2014.

    She was the medical director of Communicable Disease Prevention and Control and Public Health Emergency Management with the BCCDC and medical director for the provincial emerging and vector-borne diseases program, as well as a provincial program for surveillance and control of healthcare associated infections from 2005 to 2014.

    Dr. Henry joined Toronto Public Health in 2001 as Associate Medical Officer of Health, where she was responsible for the Emergency Services Unit and the Communicable Disease Liaison Unit. In 2003, she was the operational lead in the response to the SARS outbreak in Toronto. She was a member of the executive team of the Ontario SARS Scientific Advisory Committee.

    Dr. Henry is a specialist in public health and preventive medicine and is board certified in preventive medicine in the U.S. She graduated from Dalhousie Medical School and completed a Masters in Public Health in San Diego, residency training in preventive medicine at University of California, San Diego and in community medicine at University of Toronto.

    She has worked internationally including with the WHO/UNICEF polio eradication program in Pakistan and with the World Health Organization to control the Ebola outbreak in Uganda.

    Dr. Henry is an associate professor at the University of British Columbia, Faculty of Medicine. She is the past chair of Immunize Canada and a member of the Canadian National Advisory Committee on Immunization and the National Infection Control Guidelines Steering Committee. She chaired the Canadian Public Health Measures Task Group and was a member of the Infection Control Expert Group and the Canadian Pandemic Coordinating Committee responding to the 2009 H1N1 influenza pandemic.

    She has been involved with planning, surveillance and response to mass gatherings in Canada and internationally, including with the Vancouver 2010 Olympic and Paralympic Winter Games. She is also the author of “Soap and Water and Common Sense” a guide to staying healthy in a microbe filled world.

    New York Times: The Top Doctor Who Aced the Coronavirus Test
  • ▶ 💬 💬 𝗪𝗲 𝘀𝗶𝘁 𝗱𝗌𝘄𝗻 𝘄𝗶𝘁𝗵 𝗕𝗖’𝘀 𝗖𝗵𝗶𝗲𝗳 𝗠𝗲𝗱𝗶𝗰𝗮𝗹 𝗛𝗲𝗮𝗹𝘁𝗵 𝗢𝗳𝗳𝗶𝗰𝗲𝗿 and findmyvaccine podcast Faculty, 𝗗𝗿.𝗕𝗌𝗻𝗻𝗶𝗲 𝗛𝗲𝗻𝗿𝘆, 𝗌𝗻 𝗮 𝗿𝗮𝗻𝗎𝗲 of issues.

    💡💡🎙 Dr.Henry 𝐬𝐡𝐚𝐫𝐞𝐬 her 𝐩𝐞𝐫𝐬𝐚𝐧𝐚𝐥 𝐞𝐱𝐩𝐞𝐫𝐢𝐞𝐧𝐜𝐞 𝐧𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 an 𝐞𝐯𝐞𝐫𝐜𝐡𝐚𝐧𝐠𝐢𝐧𝐠 𝐩𝐮𝐛𝐥𝐢𝐜 𝐡𝐞𝐚𝐥𝐭𝐡 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐚𝐧𝐝 𝐥𝐞𝐬𝐬𝐚𝐧𝐬 𝐚𝐧 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐢𝐧 𝐭𝐮𝐊𝐮𝐥𝐭𝐮𝐚𝐮𝐬 𝐭𝐢𝐊𝐞𝐬.

    She also walks 𝘂𝘀 𝘁𝗵𝗿𝗌𝘂𝗎𝗵 𝗵𝗌𝘄 𝘀𝗵𝗲 𝗺𝗮𝗞𝗲𝘀 𝘀𝗌𝗺𝗲 𝗌𝗳 𝗵𝗲𝗿 𝗞𝗲𝘆 𝗱𝗲𝗰𝗶𝘀𝗶𝗌𝗻𝘀.👇

    ⚖ D𝗲𝗰𝗶𝘀𝗶𝗌𝗻𝘀 𝘄𝗶𝗹𝗹 𝗮𝗹𝘄𝗮𝘆𝘀 𝗵𝗮𝘃𝗲 𝗮 𝗰𝗌𝗺𝗜𝗌𝗻𝗲𝗻𝘁 𝗌𝗳 𝗮𝘀𝘀𝗌𝗰𝗶𝗮𝘁𝗲𝗱 𝘂𝗻𝗰𝗲𝗿𝘁𝗮𝗶𝗻𝘁𝘆.

    💡 𝗪𝗵𝗮𝘁 𝗱𝗌𝗲𝘀 𝗎𝗌𝗌𝗱 𝗜𝘂𝗯𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵 𝗱𝗲𝗰𝗶𝘀𝗶𝗌𝗻 𝗺𝗮𝗞𝗶𝗻𝗎 𝗹𝗌𝗌𝗞 𝗹𝗶𝗞𝗲 in a pandemic?

    ⚕ 𝗛𝗌𝘄 𝗱𝗌 𝘆𝗌𝘂 𝗰𝗿𝗲𝗮𝘁𝗲 𝗮 𝘀𝗲𝗻𝘀𝗲 𝗌𝗳 𝗰𝗲𝗿𝘁𝗮𝗶𝗻𝘁𝘆 𝗮𝗺𝗶𝗱𝘀𝘁 𝗮 𝗜𝗮𝗻𝗱𝗲𝗺𝗶𝗰 𝗰𝗵𝗮𝗿𝗮𝗰𝘁𝗲𝗿𝗶𝘀𝗲𝗱 𝗌𝗻𝗹𝘆 𝗯𝘆 𝘂𝗻𝗰𝗲𝗿𝘁𝗮𝗶𝗻𝘁𝘆?

    Dr. Bonnie Henry, MD MPH FRCPC, BC Provincial Health Officer

    As BC’s most senior public health official, Dr. Henry is responsible for monitoring the health of all British Columbians and undertaking measures for disease prevention and control and health protection. Most recently, Dr. Henry has led the province’s response on the COVID-19 pandemic and drug overdose emergency.

    Dr. Henry’s experience in public health, preventative medicine and global pandemics has extended throughout her career. Prior to her current role, Dr. Henry was the deputy provincial health officer for three years. She also served as the interim provincial executive medical director of the BC Centre for Disease Control (BCCDC) from December 2013 until August 2014.

    She was the medical director of Communicable Disease Prevention and Control and Public Health Emergency Management with the BCCDC and medical director for the provincial emerging and vector-borne diseases program, as well as a provincial program for surveillance and control of healthcare associated infections from 2005 to 2014.

    Dr. Henry joined Toronto Public Health in 2001 as Associate Medical Officer of Health, where she was responsible for the Emergency Services Unit and the Communicable Disease Liaison Unit. In 2003, she was the operational lead in the response to the SARS outbreak in Toronto. She was a member of the executive team of the Ontario SARS Scientific Advisory Committee.

    Dr. Henry is a specialist in public health and preventive medicine and is board certified in preventive medicine in the U.S. She graduated from Dalhousie Medical School and completed a Masters in Public Health in San Diego, residency training in preventive medicine at University of California, San Diego and in community medicine at University of Toronto.

    She has worked internationally including with the WHO/UNICEF polio eradication program in Pakistan and with the World Health Organization to control the Ebola outbreak in Uganda.

    Dr. Henry is an associate professor at the University of British Columbia, Faculty of Medicine. She is the past chair of Immunize Canada and a member of the Canadian National Advisory Committee on Immunization and the National Infection Control Guidelines Steering Committee. She chaired the Canadian Public Health Measures Task Group and was a member of the Infection Control Expert Group and the Canadian Pandemic Coordinating Committee responding to the 2009 H1N1 influenza pandemic.

    She has been involved with planning, surveillance and response to mass gatherings in Canada and internationally, including with the Vancouver 2010 Olympic and Paralympic Winter Games. She is also the author of “Soap and Water and Common Sense” a guide to staying healthy in a microbe filled world.

    New York Times: The Top Doctor Who Aced the Coronavirus Test
  • Dr. Karl Weiss, M.D., M. Sc., FRCPC


    Le Dr Karl Weiss est microbiologiste et spécialiste en maladies infectieuses à l’HÃŽpital général juif de Montréal ainsi que professeur à la Faculté de médecine de l’Université McGill. Il est chef de la Division des maladies infectieuses de l’HÃŽpital général juif de Montréal, qui est l’hÃŽpital ayant le plus important volume clinique en maladies infectieuses au Canada.

    Il a œuvré comme microbiologiste-infectiologue à l’HÃŽpital Maisonneuve-Rosemont de 1994 à 2016, et y a occupé de trÚs nombreuses fonctions, dont celle de chef de département durant plusieurs années. Il est également professeur titulaire de clinique à la Faculté de médecine de l’Université de Montréal et a été directeur de la recherche pharmacologique à l’HÃŽpital Maisonneuve-Rosemont de 2001 à 2013. Il a également été coprésident de la Table en prévention et contrÃŽle des infections de l’Île de Montréal.

    AprÚs avoir reçu son doctorat en médecine de l’Université de Montréal en 1989, le Dr Weiss a poursuivi ses études en médecine interne à l’Université de Montréal et à l’Université McGill, puis a terminé sa formation en maladies infectieuses et en microbiologie à l’Université de Montréal. Il a également effectué des études postdoctorales et obtenu une maîtrise en épidémiologie clinique. Il a étudié de nouvelles méthodes de détection et de nouveaux antibiotiques dans le traitement des infections à Helicobacter pylori.

    Au cours de sa carriÚre, le Dr Weiss a participé comme invité à plus de 500 conférences au Canada et à l’international. Il a présenté ou publié plus de 400 résumés et articles dans des journaux prestigieux comme The New England Journal of Medicine, The Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Canadian Journal of Infectious Diseases, American Journal of Epidemiology, Clinical Infectious Diseases and Infection Control and Hospital Epidemiology. Ses recherches se concentrent principalement sur les infections des voies respiratoires, les antibiotiques et la résistance antimicrobienne. L’équipe de recherche du Dr Weiss a souvent été l’une des premiÚres au Canada à travailler avec les nouveaux antibiotiques en développement.

    Le Dr Weiss est aussi le président de l’Association des médecins microbiologistes-infectiologues du Québec (AMMIQ) et il a présidé de nombreux comités québécois et canadiens dans le domaine des maladies infectieuses. En 2005, il a été le président du CongrÚs mondial sur la pneumonie, qui s’est tenu à Montréal. Par ailleurs, il a présidé le jury d’examen en microbiologie médicale du CollÚge royal des médecins et chirurgiens du Canada entre 2002 et 2005. Il a longtemps siégé à l’exécutif de l’Association canadienne de microbiologie médicale et d’infectiologie (AMMI Canada) et a représenté cet organisme à plusieurs comités.

    Il a reçu le prix Distinction de la Société canadienne des maladies infectieuses en 2005 et le prix Médecin de cœur et d’action de l’Association des médecins de langue française du Canada en 2008. Le Dr Weiss est trÚs souvent sollicité par les médias pour discuter de problÚmes liés aux maladies infectieuses.

  • "𝗜’𝘃𝗲 𝗵𝗮𝗱 𝘁𝘄𝗌 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝗱𝗌𝘀𝗲𝘀 𝗮𝗻𝗱 𝗱𝗌𝗻’𝘁 𝗳𝗲𝗲𝗹 𝗮𝗻𝘆 𝘂𝗿𝗎𝗲𝗻𝗰𝘆 𝘁𝗌 𝗎𝗲𝘁 𝗮 𝘁𝗵𝗶𝗿𝗱."

    𝗪𝗲 𝘀𝗶𝘁 𝗱𝗌𝘄𝗻 𝘄𝗶𝘁𝗵 𝟮 𝗶𝗻𝗳𝗲𝗰𝘁𝗶𝗌𝘂𝘀 𝗱𝗶𝘀𝗲𝗮𝘀𝗲 𝗲𝘅𝗜𝗲𝗿𝘁𝘀 𝗮𝗻𝗱 𝗰𝗵𝗮𝘁 𝗮𝗯𝗌𝘂𝘁 𝗖𝗢𝗩𝗜𝗗-𝟭𝟵 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗯𝗌𝗌𝘀𝘁𝗲𝗿𝘀. 𝗗𝗿.𝗊𝗿𝗶𝗻𝗶𝘃𝗮𝘀 𝗠𝘂𝗿𝘁𝗵𝘆 𝗮𝗻𝗱 𝗗𝗿.𝗔𝗹𝗌𝗻 𝗩𝗮𝗶𝘀𝗺𝗮𝗻 𝗲𝘅𝗜𝗹𝗌𝗿𝗲 𝗵𝗌𝘄 𝘁𝗌 𝗲𝗳𝗳𝗲𝗰𝘁𝗶𝘃𝗲𝗹𝘆 𝗳𝗿𝗮𝗺𝗲 𝘁𝗵𝗲 𝗯𝗌𝗌𝘀𝘁𝗲𝗿 𝗰𝗌𝗻𝘃𝗲𝗿𝘀𝗮𝘁𝗶𝗌𝗻 𝘄𝗶𝘁𝗵 𝗜𝗮𝘁𝗶𝗲𝗻𝘁𝘀. 𝗪𝗶𝘁𝗵 𝘄𝗮𝗻𝗶𝗻𝗎 𝗱𝗲𝗺𝗮𝗻𝗱 𝘀𝗵𝗌𝘂𝗹𝗱 𝘄𝗲 𝗯𝗲 𝘁𝗵𝗶𝗻𝗞𝗶𝗻𝗎 𝗌𝗳 𝗮𝗱𝗱𝗶𝗻𝗎 𝗮 𝗯𝗌𝗌𝘀𝘁𝗲𝗿 𝗿𝗲𝗟𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁 𝘁𝗌 𝘃𝗮𝗰𝗰𝗶𝗻𝗲 𝗰𝗲𝗿𝘁𝗶𝗳𝗶𝗰𝗮𝘁𝗲𝘀?

    𝗛𝗮𝘀 𝗺𝗲𝘀𝘀𝗮𝗎𝗶𝗻𝗎 𝗳𝗿𝗌𝗺 𝗜𝘂𝗯𝗹𝗶𝗰 𝗵𝗲𝗮𝗹𝘁𝗵 𝗹𝗲𝗮𝗱𝗲𝗿𝘀 𝗮𝗻𝗱 𝗳𝗿𝗌𝗻𝘁𝗹𝗶𝗻𝗲 𝗛𝗖𝗣𝘀 𝗮𝗿𝗌𝘂𝗻𝗱 𝘁𝗵𝗲 𝗶𝗺𝗜𝗌𝗿𝘁𝗮𝗻𝗰𝗲 𝗌𝗳 𝘁𝗵𝗲 𝗯𝗌𝗌𝘀𝘁𝗲𝗿 𝗱𝗌𝘀𝗲 𝗯𝗲𝗲𝗻 𝗰𝗹𝗲𝗮𝗿 𝗲𝗻𝗌𝘂𝗎𝗵?

    𝗊𝗵𝗌𝘂𝗹𝗱 𝘄𝗲 𝗲𝘃𝗲𝗻 𝗰𝗮𝗹𝗹 𝗶𝘁 𝗮 𝗯𝗌𝗌𝘀𝘁𝗲𝗿 𝗱𝗌𝘀𝗲? 𝗜𝘀 𝗶𝘁 𝗯𝗲𝘁𝘁𝗲𝗿 𝗱𝗲𝘀𝗰𝗿𝗶𝗯𝗲𝗱 𝗮𝘀 𝗯𝗲𝗶𝗻𝗎 𝗳𝘂𝗹𝗹𝘆 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗲𝗱? 𝗙𝘂𝗹𝗹𝘆 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗲𝗱 𝘄𝗶𝘁𝗵 𝗮𝗻 𝗮𝗱𝗱𝗶𝘁𝗶𝗌𝗻𝗮𝗹 𝗱𝗌𝘀𝗲? 𝗧𝗿𝗶𝗜𝗹𝗲 𝘃𝗮𝗰𝗰𝗶𝗻𝗮𝘁𝗲𝗱?

    𝗧𝗵𝗲 𝗜𝗮𝗻𝗲𝗹 𝗮𝗹𝘀𝗌 𝗮𝗻𝘀𝘄𝗲𝗿𝘀 𝗮𝗹𝗹 𝘆𝗌𝘂𝗿 𝗯𝘂𝗿𝗻𝗶𝗻𝗎 𝗖𝗢𝗩𝗜𝗗 𝗯𝗌𝗌𝘀𝘁𝗲𝗿 𝗟𝘂𝗲𝘀𝘁𝗶𝗌𝗻𝘀 𝗳𝗿𝗌𝗺 𝘁𝗵𝗲 𝗳𝗿𝗌𝗻𝘁𝗹𝗶𝗻𝗲𝘀.

    Dr. Srinivas Murthy MD MASc FRCPC is the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research, and co-chair of the World Health Organization’s (WHO) clinical research committee on COVID-19. He is an associate professor in the Faculty of Medicine at University of British Columbia, as well as a critical care and infectious diseases physician at B.C. Children’s Hospital in Vancouver. Murthy’s research focuses on infectious disease, clinical practice and clinical trials, and global health. He has also worked on the frontlines for a number of infectious disease outbreaks, including work on Ebola in Liberia, West Africa.

    Dr.Alon Vaisman MD MAS FRCPC is an Infectious Diseases and Infection Control Physician at the University Health Network and the University of Toronto.

  • ‘𝗜’𝗺 𝗱𝗌𝗻𝗲 𝘄𝗶𝘁𝗵 𝗖𝗢𝗩𝗜𝗗’ 𝗶𝘀 𝗲𝗮𝘀𝗶𝗲𝗿 𝘀𝗮𝗶𝗱 𝘁𝗵𝗮𝗻 𝗱𝗌𝗻𝗲-𝑚𝒏𝒅𝒓𝒆 𝑷𝒊𝒄𝒂𝒓𝒅, 𝑮𝒍𝒐𝒃𝒆 𝒂𝒏𝒅 𝑎𝒂𝒊𝒍 𝑱𝒂𝒏.24𝒕𝒉 2022

    🎙🎙🎙 𝗙𝗿𝗌𝗺 𝗖𝗢𝗩𝗜𝗗 𝗿𝗲𝘀𝘁𝗿𝗶𝗰𝘁𝗶𝗌𝗻𝘀 𝗮𝗻𝗱 𝗶𝗺𝗜𝗹𝗶𝗰𝗮𝘁𝗶𝗌𝗻𝘀 𝗳𝗌𝗿 𝘁𝗵𝗲 “𝗻𝗲𝘅𝘁 𝗻𝗌𝗿𝗺𝗮𝗹”, 𝘁𝗌 𝘁𝗵𝗲 𝗳𝘂𝗻𝗱𝗮𝗺𝗲𝗻𝘁𝗮𝗹 𝘀𝗵𝗶𝗳𝘁𝘀 𝗶𝗻 𝗜𝘂𝗯𝗹𝗶𝗰 𝗮𝘁𝘁𝗶𝘁𝘂𝗱𝗲𝘀 𝘁𝗌𝘄𝗮𝗿𝗱𝘀 𝗵𝗌𝘄 𝗖𝗮𝗻𝗮𝗱𝗶𝗮𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝘀 𝗱𝗲𝗹𝗶𝘃𝗲𝗿𝗲𝗱, 𝗌𝗻𝗲 𝗌𝗳 𝗖𝗮𝗻𝗮𝗱𝗮'𝘀 🇚🇊 𝘁𝗌𝗜 𝗵𝗲𝗮𝗹𝘁𝗵 𝗮𝗻𝗱 𝗜𝘂𝗯𝗹𝗶𝗰 𝗜𝗌𝗹𝗶𝗰𝘆 𝗌𝗯𝘀𝗲𝗿𝘃𝗲𝗿𝘀 𝗮𝗻𝗱 𝗰𝗌𝗺𝗺𝗲𝗻𝘁𝗮𝘁𝗌𝗿𝘀, 𝗔𝗻𝗱𝗿é 𝗣𝗶𝗰𝗮𝗿𝗱 𝗷𝗌𝗶𝗻𝘀 𝘂𝘀 𝗶𝗻 𝘀𝘁𝘂𝗱𝗶𝗌.

    📰 𝗪𝗲 𝗲𝘅𝗜𝗹𝗌𝗿𝗲 𝘀𝗵𝗶𝗳𝘁𝘀 𝗶𝗻 𝗷𝗌𝘂𝗿𝗻𝗮𝗹𝗶𝘀𝗺 𝗮𝗻𝗱 𝘁𝗵𝗲 𝗿𝗌𝗹𝗲 𝗌𝗳 𝘁𝗵𝗲 𝗺𝗲𝗱𝗶𝗮 𝗱𝘂𝗿𝗶𝗻𝗎 𝗮 𝗜𝗮𝗻𝗱𝗲𝗺𝗶𝗰, 𝗮𝘀 𝘄𝗲𝗹𝗹 𝗮𝘀 𝗜𝗌𝗞𝗲 𝘁𝗵𝗲 𝗜𝗲𝗿𝗲𝗻𝗻𝗶𝗮𝗹 𝗜𝘂𝗯𝗹𝗶𝗰 𝘃𝘀.(𝗌𝗿 𝗮𝗻𝗱) 𝗜𝗿𝗶𝘃𝗮𝘁𝗲 𝗱𝗲𝗯𝗮𝘁𝗲 𝗶𝗻 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲.

    🔑🔑💡𝗛𝗌𝘄 𝗱𝗌𝗲𝘀 𝗔𝗻𝗱𝗿é 𝗮𝗜𝗜𝗿𝗌𝗮𝗰𝗵 𝗵𝗶𝘀 𝗜𝗶𝗲𝗰𝗲𝘀 𝗶𝗻 𝘁𝗵𝗲 𝗚𝗹𝗌𝗯𝗲 𝗮𝗻𝗱 𝗱𝗌𝗲𝘀 𝗵𝗲 𝗲𝘃𝗲𝗿 𝗵𝗮𝘃𝗲 𝘄𝗿𝗶𝘁𝗲𝗿’𝘀 𝗯𝗹𝗌𝗰𝗞?

    𝗔𝗕𝗢𝗚𝗧 𝗔𝗻𝗱𝗿é 𝗣𝗶𝗰𝗮𝗿𝗱

    André Picard is one of Canada's top health and public policy observers and commentators. Currently the health columnist at The Globe and Mail, he has been a staff writer for over 30 years. Picard is also the author of five books and has received acclaim for his writing and for his dedication to improving health care. In 2010, he was awarded a National Newspaper Award as Canada's top newspaper columnist.

  • Dr.Brian Conway, MD, FRCPC Infectious Disease Physician

    Medical Director - Vancouver Infectious Diseases Centre (VIDC)

    Dr. Brian Conway is the Medical Director of the Vancouver Infectious Diseases Centre (VIDC), specializing in the diagnosis and treatment of chronic infectious diseases and related conditions, with a focus on HIV and HCV infections. At VIDC, he is the Principal Investigator for over 25 HIV and HCV clinical research trials, and is credited with the conceptualization and implementation of the ENTENTE (Engage, Test, Engage, Treat, Engage) program that led to the development of VIDC’s Community Pop-Up Clinics (CPCs).

    The VIDC’s CPCs provide point-of-care testing for HIV and HCV in Vancouver’s Downtown East Side (DTES). Over 500 patients have been diagnosed with HCV and engaged in care through this program, and over 150 have already received HCV treatment. His leadership with the CPCs has led to the development of novel strategies for the delivery of care emphasizing the simplification of therapeutic options and integration of medical, addiction, social, and psychological aspects of care.

    Recent Media:

    Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized PatientsCOVID-19: B.C. should be prepared to abandon six-month wait for booster, Dr. Brian ConwayMedical experts weigh in on new COVID measures brought in by B.C. government.Canucks and COVID: Omicron virus variant vigilance vital for NHL, says diseases centre doc
  • Dr.Santa Ono
    President and Vice-Chancellor - University of British Columbia

    Santa J. Ono PhD FRSC FCAHS is the 15th President & Vice-Chancellor of the University of British Columbia.

    Installed as President and Vice-Chancellor in 2016, he also serves as Chair of the U15 Group of Universities, on the Board of Directors of Universities Canada, and as Past Chair of Research Universities of British Columbia. He is also a member of the Boards of Fulbright and MITACS. He has also served on the Boards of the American Council on Education and the Council on Competitiveness and as Chief Innovation Advisor to the Province of British Columbia.

    Prior to his appointment as President and Vice-Chancellor of UBC, Dr. Ono served as the 28th President of the University of Cincinnati and Senior Vice-Provost and Deputy to the Provost at Emory University.

    He was appointed by Governor John Kasich to lead Ohio’s Biopharmaceutical Task Force and to the Board of the Ohio Third Frontier – Ohio’s technology-based economic development program, when he served as President of the University of Cincinnati.

    A molecular immunologist educated at the University of Chicago and McGill, Dr. Ono has taught at Johns Hopkins, Harvard University and University College London. He has advised national and regional governments on higher education and mental health. He has also advised companies such as GSK, Johnson & Johnson, Merck and Novartis on R&D.

    He has served on a number of editorial boards, including Immunology, The Journal of Biological Chemistry, The Journal of Immunology and The Journal of Allergy & Clinical Immunology.

    Dr. Ono has been inducted as a Fellow of the American Association for the Advancement of Science, the Canadian Academy of Health Sciences, the National Academy of Inventors, USA and the Johns Hopkins Society of Scholars.

    He holds Honorary Doctorates from Chiba University and the Vancouver School of Theology and is a recipient of the Reginald Wilson Diversity Leadership Award from the American Council on Education, the Professional Achievement Award from University of Chicago, a Grand Challenges Hero Award from UCLA and the NAAAP 100 Award from the National Association of Asian American Professionals.

    Listen to the Blue and Gold Podcast with Professor OnoThe National Forum on Anti-Asian Racism Final Report: https://events.ubc.ca/wp-content/uploads/2021/10/UBC-National-Forum-Anti-Asian-Racism-Report_18-Oct-2021_web.pdf
  • Dr. Katharine Smart, CMA President

    Dr. Katharine Smart is a pediatrician in Whitehorse, Yukon. Her work is centered on developing collaborative partnerships with community and government services to serve marginalized children using a model of social pediatrics. She works primarily with children who have experienced trauma and adverse childhood events, and she witnesses the broad and lasting impact these events have on children and their development daily. She is passionate about improving services for marginalized children in an effort to change their life trajectory.

    In addition to her community-based work, Dr. Smart enjoys acute care and provides on-call services to the hospital. Before moving to the Yukon, she was a pediatric emergency medicine physician at the Alberta Children’s Hospital in Calgary. Dr. Smart is the past president of the Yukon Medical Association.